Last: | $90.61 |
---|---|
Change Percent: | -0.86% |
Open: | $90.68 |
Close: | $90.61 |
High: | $90.805 |
Low: | $90.08 |
Volume: | 34,161,066 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$90.61 | $90.68 | $90.61 | $90.805 | $90.08 | 34,161,066 | 07-02-2024 |
$89.91 | $90.42 | $89.91 | $91.08 | $89.82 | 49,735,376 | 07-01-2024 |
$91.4889 | $93.4327 | $91.4889 | $93.4676 | $91.4889 | 55,119,554 | 06-28-2024 |
$93.52 | $93.52 | $93.52 | $93.71 | $93.42 | 23,140,767 | 06-27-2024 |
$93.15 | $93.28 | $93.15 | $93.465 | $93.11 | 38,489,135 | 06-26-2024 |
$94.5 | $94.07 | $94.5 | $94.55 | $94.04 | 23,160,000 | 06-25-2024 |
$94.34 | $94.05 | $94.34 | $94.34 | $93.735 | 56,939,096 | 06-24-2024 |
$93.96 | $94.24 | $93.96 | $94.479 | $93.59 | 22,830,882 | 06-21-2024 |
$93.96 | $93.41 | $93.96 | $94 | $93.34 | 30,246,274 | 06-20-2024 |
$94.59 | $93.89 | $94.59 | $94.6 | $93.73 | 26,881,038 | 06-19-2024 |
$94.59 | $93.89 | $94.59 | $94.6 | $93.73 | 26,881,038 | 06-18-2024 |
$93.73 | $93.52 | $93.73 | $93.81 | $93.28 | 31,040,202 | 06-17-2024 |
$94.67 | $94.42 | $94.67 | $94.84 | $94.24 | 28,776,710 | 06-14-2024 |
$93.88 | $93.22 | $93.88 | $93.99 | $92.95 | 33,093,758 | 06-13-2024 |
$92.52 | $93.02 | $92.52 | $93.57 | $92.485 | 42,554,583 | 06-12-2024 |
$91.83 | $91.032 | $91.83 | $91.87 | $90.9223 | 30,329,207 | 06-11-2024 |
$90.89 | $91 | $90.89 | $91.06 | $90.65 | 20,593,244 | 06-10-2024 |
$91.5 | $91.83 | $91.5 | $91.83 | $91.4 | 35,240,475 | 06-07-2024 |
$93.21 | $92.92 | $93.21 | $93.43 | $92.86 | 22,891,863 | 06-06-2024 |
$93.35 | $93 | $93.35 | $93.35 | $92.3887 | 43,153,858 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
iShares 20+ Year Treasury Bond ETF Company Name:
TLT Stock Symbol:
NASDAQ Market:
TORONTO, ON / ACCESSWIRE / June 20, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...
TORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...
TORONTO, ON / ACCESSWIRE / April 14, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their form...